Koers EnteroMedics Inc Nasdaq
Aandelen
US29365M2089
Geavanceerde medische apparatuur & technologie
Omzet 2022 | 11,24 mln. 10,49 mln. | Omzet 2023 | 8,68 mln. 8,1 mln. | Marktkapitalisatie | 4,62 mln. 4,32 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -46 mln. -42,95 mln. | Nettowinst (verlies) 2023 | -11 mln. -10,27 mln. | EV/omzet 2022 | -0,04 x |
Nettoliquiditeiten 2022 | 3,68 mln. 3,44 mln. | Nettoliquiditeiten 2023 | 4,2 mln. 3,92 mln. | EV/omzet 2023 | 0,05 x |
K/w-verhouding 2022 |
-0,06
x | K/w-verhouding 2023 |
-0,13
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 88,83% |
Recentste transcriptie over EnteroMedics Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Hickey
CEO | Chief Executive Officer | 59 | 01-02-20 |
Director of Finance/CFO | 63 | 15-06-21 | |
Dov Gal
CMP | Compliance Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gary Blackford
BRD | Director/Board Member | 66 | 01-01-16 |
Dan Gladney
CHM | Chairman | 70 | 01-11-15 |
Director/Board Member | 70 | 15-06-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,00% | 185 mld. | |
+31,86% | 158 mld. | |
+33,21% | 113 mld. | |
+2,28% | 64,32 mld. | |
+21,14% | 55,66 mld. | |
+0,11% | 48,41 mld. | |
-6,76% | 37,82 mld. | |
+0,78% | 35,57 mld. | |
+11,28% | 28,12 mld. |